Investor FAQs

Investor FAQs

What does Establishment Labs do?
Establishment Labs is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or a direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers.
On what stock exchange are Establishment Labs shares traded, and what is the ticker symbol?
Establishment Labs is listed on the NASDAQ and traded under the ticker symbol ESTA.
Does Establishment Labs have a direct stock purchase plan?
We do not currently have a direct stock purchase plan.
Where can I find Establishment Labs’ current & historic share price?
Please refer to the Stock Information section of the website, which allows you to look at both current and historic share price data.
How can I purchase Establishment Labs’ common stock?
Establishment Labs’ common stock may be purchased through a registered broker on the open market.
Where can I find all of Establishment Labs’ regulatory filings, including quarterly and annual reports?
Quarterly and annual reports, as well as other regulatory filings, can be accessed on the SEC Filings section of our website or on the SEC’s website: www.sec.com.
When does Establishment Labs’ fiscal year end?
Our fiscal year ends December 31.
When is Establishment’s Annual Stockholders Meeting?
At this time, the details for the next meeting have not yet been determined.
Does Establishment Labs pay cash dividends?
We do not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
Who are the company’s independent registered public accountants?
Marcum LLP.
Who is the company’s transfer agent?
Our transfer agent is Computershare. They can be reached at:

Computer Share Investor Services
Computershare
P.O. Box 505000
Louisville, KY 40233-5000
1- 877-373-6374 (US, Canada, Puerto Rico)
1- 781-575-3100 (non-US)
www.computershare.com/investor

By overnight delivery:
Computershare
462 South 4th Street, Suite 1600
Louisville KY 40202

Email: web.queries@computershare.com

Shareholder Online Inquiries: https://www-us.computershare.com/investor/Contact
Who is the company’s outside legal counsel?
The company is represented by Wilson Sonsini Goodrich & Rosati.
When did Establishment Labs become a publicly traded company?
Our company began listing on the NASDAQ on July 19, 2018.
How do I contact Investor Relations with a question or request?
You can contact Establishment Labs Investor Relations via email at: IR@establishmentlabs.com. In addition, you can reach Investor Relations by calling 212-445-8084.
Where is Establishment Labs’ corporate headquarters?
Establishment Labs is headquartered in Coyol Free Zone, Alajuela, Costa Rica.
How can I be added to Establishment Labs’ mailing list?
You can sign up for e-mail alerts notifying you of press releases, SEC filings or corporate news and events by clicking here.